StockRing.com   Home    DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH   
  iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   
 5/23/2013, (NASDAQ:PFE), $29.3 +0.52, +1.81%, "SELL" Pfize Stock
 




  Enter Stock
  
  
   
On   5/23/2013   StockRing.com recommends to   "SELL"   PFE   stock at current price of   $29.3.
Today PFE stock opened at $29.55 and was trading in the daily range of $ 355500 per share.
Pfize (NASDAQ:PFE) Market capitalization is $207.8B. PFE average daily volume is N/A.
On last trading session PFE stock traded 83,679,480 shares. Also the Short Ratio for (NASDAQ:PFE) stock is 57.601B.
Last year Pfize(NASDAQ:PFE) before taxes (EBITDA) (ttm) earned $29.61 on revenue of $2.48.
PFE 50-Day Moving Average is $25.335B vs. $29.3 now and 200-Day Moving Average is $29.65 vs. $29.3.
--------------------------------------------------------------------------------------------------------------------
VIX has "BUY" rating.  Nasdaq has "SUPER BUY" rating.  S&P 500 has "SUPER BUY" rating on  5/22/2013
1200 Stocks: Buy 64% 766,  Sell 8% 96,  Hold 28% on  5/21/2013
Our Best sector to "Buy" is Services with 74% or 149 stocks to BUY last rated on 5/21/2013
Our Worst sector to "Sell" is Health with 14% or 29 stocks to SELL rated on 5/21/2013
--------------------------------------------------------------------------------------------------------------------
PFE Earnings Per Share - EPS (ttm) is 2.09. PFE Stock Price Per Earnings ratio - P/E is 13.78.
Pfize(NASDAQ:PFE)
stock pays a dividend of $ Inc. Comm" per share which is a yield of "NYSE"%.
On average analysts predict that One Year Target Estimated price for PFE stock is $27.25.
In the last 52 weeks PFE stock was trading in the range of $21.40 - 31.15.
 
 
BUY  DOW 30+: AEE  FLR  NRG  PCG  RL     ENERGY: APA  AREX  COG  CRZO  DO     HEALTH: MCK  MGLN  SNN  STJ  ZLTQ 
      FINANCE: BLK  CIT  CNS  GNW  HBC     SERVICES: AVB  BXP  CTL  DTV  EQR     TECH: BRKR  CPHD  CSGP  MDRX  NUAN 
SELL  DOW 30+: ETR  KMB  TRV  MOS  LFL     ENERGY: NS  TLP  E  NTI  CAK     HEALTH: CPIX  GTIV  ACOR  AFAM  ACHC 
      FINANCE: AWH  BBVA  NLY  TRV  VR     SERVICES: AMX  NTT  CCL  SWY  TV     TECH: QLGC  TSM  APH  ARMH  CAVM 

Our FREE iPhone App gives Buy-Sell-Hold ratings for 1,200 stocks!
 1. Dow 30+ - 200 Stocks   on 5/22/2013:   Buy   60% or 121    Hold   30% or 60    Sell   10% or 19
 2. Energy - 200 Stocks   on 5/21/2013:   Buy   72% or 145    Hold   25% or 49    Sell   3% or 6
 3. Health - 200 Stocks   on 5/21/2013:   Buy   46% or 93    Hold   40% or 78    Sell   14% or 29
 4. Finance - 200 Stocks   on 5/21/2013:   Buy   70% or 139    Hold   22% or 45    Sell   8% or 16
 5. Services - 200 Stocks   on 5/21/2013:   Buy   74% or 149    Hold   22% or 42    Sell   4% or 9
 6. Tech - 200 Stocks   on 5/21/2013:   Buy   60% or 119    Hold   32% or 64    Sell   8% or 17
 
  TOTAL RATING:   Buy   64% or 766    Hold   28% or 338    Sell   8% or 96 

Samples of StockRing Real Time "Buy-Sell-Hold" stock Ratings:



  Enter Stock:  
  
    
    
 
 



Download StockRing Free  Buy-Sell-Hold iPhone
App for 1,200 stocks in Energy Healthcare Finance Services & Tech


DOW 30+

ENERGY

HEALTH

FINANCE

SERVICES

TECH

BUY  DOW 30+: XOM  WSM  WPZ  WLK  WHR     ENERGY: YZC  YPF  XOM  XCO  WTI     HEALTH: ZMH  ZLTQ  WX  WST  WOOF 
      FINANCE: ZION  Y  XLI  XLB  WSH     SERVICES: YUM  YHOO  WYNN  WU  WTW     TECH: XRX  XLNX  WDC  WCC  WAT 
SELL  DOW 30+: TRV  T  SYT  POT  PFE     ENERGY: TLP  NTI  NS  LRE  E     HEALTH: WCG  VHS  UHS  THOR  SPNC 
      FINANCE: WRB  VR  TRV  TCB  NLY     SERVICES: URBN  TV  SWY  NTT  CUK     TECH: TSM  SNDK  SLH  SAP  RHT 

 
DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

Our FREE iPhone App gives Buy-Sell-Hold ratings for 1,200 stocks!
 1. Dow 30+ - 200 Stocks   on 5/22/2013:   Buy   60% or 121    Hold   30% or 60    Sell   10% or 19
 2. Energy - 200 Stocks   on 5/21/2013:   Buy   72% or 145    Hold   25% or 49    Sell   3% or 6
 3. Health - 200 Stocks   on 5/21/2013:   Buy   46% or 93    Hold   40% or 78    Sell   14% or 29
 4. Finance - 200 Stocks   on 5/21/2013:   Buy   70% or 139    Hold   22% or 45    Sell   8% or 16
 5. Services - 200 Stocks   on 5/21/2013:   Buy   74% or 149    Hold   22% or 42    Sell   4% or 9
 6. Tech - 200 Stocks   on 5/21/2013:   Buy   60% or 119    Hold   32% or 64    Sell   8% or 17
 
  TOTAL RATING:   Buy   64% or 766    Hold   28% or 338    Sell   8% or 96 
 
DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

Our FREE iPhone App with Buy-Sell-Hold ratings for 1,200 stocks:

  iPhone App Buy-Sell-Hold Ratings for 5-5-2013
           
           
           
           
     
  

 
  Enter Stock:  
  
    
    
 



5/23/2013  Thursday, May 23, 2013 (Irvine, California) Today StockRing.com Recommendation is to "SELL"for Pfize (NASDAQ:PFE) Stock. PFE stock opening price was $29.55 per share. Current price of NASDAQ:PFE Stock is $29.3 per share and it is $+0.52, (+1.81%) today and it was trading in the daily range of $355500 per share. Current Bid Price for (NASDAQ:PFE) stock is $3.20 and the Ask Price is $29.40. In the last 52 weeks PFE stock was trading in the range of $21.40 - 31.15. 50-Day Moving Average for (NASDAQ:PFE) stock is $25.335B and 200-Day Moving Average is $29.65. On average analysts predict that One Year Target Estimated price for (NASDAQ:PFE) stock is $27.25.

Pfize (NASDAQ:PFE) is rated as a sell on 5/22/2013 2:39:16 PM.

Pfize (NASDAQ:PFE) Market capitalization is $207.8B. (NASDAQ:PFE) stock average daily volume is N/A shares per day. However, on last trading session of May 22, 2012 PFE stock traded 83,679,480 shares. Also The Number of days it would take short sellers on average to repurchase all the borrowed shares or Short Ratio for (NASDAQ:PFE) stock is 57.601B. On previous trading session PFE Stock closed at $28.78 per share.

Last year Pfize (NASDAQ:PFE) before taxes (EBITDA) (ttm) earned $29.61 on total revenue of $2.48. Earnings Per Share - EPS (ttm) for PFE stock is 2.09. Also, (NASDAQ:PFE) Stock Price Per Earnings ratio - P/E is 13.78. Thus, (NASDAQ:PFE) Stock Price/Sales (ttm) ratio is 31.47 and Price/Book (mrq) ratio is 3.54.

(NASDAQ:PFE) Stock pays a dividend of $ Inc. Comm" per share which is a yield of "NYSE"%. So at this time (NASDAQ:PFE) Stock maintains Trailing Annual Dividend Rate at 1.80.


StockRing Recommendations for Pfize (NASDAQ:PFE) Stock are updated daily here

http://StockRing.com/sr/Buy-Sell-Hold-Stock-Analysis-Ratings.asp?StockName=PFE

At this time StockRing recommends to buy LONG positions on many stocks from Dow 30+ stocks that currently have a BUY or SUPER BUY rating. If you decide to take a SHORT position and actually sell some stocks sjort right now - please check the section of Dow 30+ stocks that have a SELL or SUPER SELL rating.

If you would like to receive Buy-Sell-Hold ratings for stocks from Energy, Healthcare, Finance, Services & Hi-Tech sectors on your iPhone, then please download Buy-Sell-Hold iPhone App here:


Free Limited or $10 Full Version  Buy-Sell-Hold iPhone App
for 1,200 stocks in Energy, Healthcare, Finance, Services and Tech


DOW 30+

ENERGY

HEALTH

FINANCE

SERVICES

TECH


 
  Enter Stock:  
  
    
    
 

 
DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

NASDAQ:PFE Stock Charts:   1d   5d   3m   6m   1y   2y   5y   Max    Options   More Info

5/23/2013 1 Year Stock market price chart for Pfize (NASDAQ:PFE) Stock on Thursday, May 23, 2013
  
1 Year PFE 1 Year Dow Jones
1 Year Nasdaq 1 Year S&P 500
5/23/2013 5 days Stock market price chart for Pfize (NASDAQ:PFE) Stock on Thursday, May 23, 2013
  
5 Days PFE 5 Days Dow Jones
5 Days Nasdaq 5 Days S&P 500
  

EUROs for $1 DOLLAR: 30 days
     

NASDAQ:PFE Stock Charts:   1d   5d   3m   6m   1y   2y   5y   Max    Options   More Info
 
DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

5/23/2013 Stock market price quote data for Pfize (NASDAQ:PFE) Stock on Thursday, May 23, 2013

Last Trade: 29.3
Trade Time: May 22
Change: +0.52, (+1.81%)
Prev Close: 28.78
Open: 29.55
Bid: 3.20
Ask: 0.92
1y Target Est: $27.25
50-Day Moving Average: 25.335B
200-Day Moving Average:
29.65
Short Ratio: 57.601B
Trailing Annual Dividend Rate: 1.80
Day's Range: 355500
52wk Range: 21.40 - 31.15
Volume: 83,679,480
Avg Vol: N/A
Market Cap: 207.8B
P/E (ttm): 13.78
EPS (ttm): 2.09
Div & Yield: Inc. Comm" ("NYSE"%)
Revenue (ttm): 2.48
Earnings before Tax (EBITDA) (ttm): 29.61
Price/Sales (ttm): 31.47
Price/Book (mrq): 3.54
 
DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

  
  
 
DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

PFIZER INC(NYSE: PFE) Company Information

Pfizer Inc.
235 East 42nd Street
New York, NY 10017
United States - Map
Phone: 212-573-2323
Fax: 212-573-7851
Web Site: http://www.pfizer.com

PFIZER INC(NYSE: PFE) DETAILS

PFIZER INC(NYSE: PFE) Index Membership: Dow Jones Composite Dow Industrials S&P 100 S&P 500 S&P 1500 Super Comp
PFIZER INC(NYSE: PFE) Sector: Healthcare
PFIZER INC(NYSE: PFE) Industry: Drug Manufacturers - Major
PFIZER INC(NYSE: PFE) Full Time Employees: 75,400

PFIZER INC(NYSE: PFE) BUSINESS SUMMARY

Pfizer Inc. engages in the discovery, development, manufacture, and marketing of prescription medicines for humans and animals worldwide. Its Pharmaceutical segment offers Lipitor for elevated cholesterol levels in the blood; Norvasc for hypertension; Caduet for cardiovascular events; Chantix/Champix for smoking cessation; Lyrica for neuropathic pain; Geodon/Zeldox, a psychotropic agent; and Aricept for Alzheimer?s disease. It also provides Celebrex for arthritis pain, and inflammation and acute pain; Vfend for esophageal candidiasis and blood stream infections; Zyvox for bacterial infections; and Selzentry/Celsentri for adults infected with only CCR5-tropic HIV-1 detectable. In addition, this segment provides Viagra for erectile dysfunction; Detrol and Toviaz for overactive bladder; Camptosar for metastatic colorectal cancer; Sutent, an oral multi-kinase inhibitor; Xalatan/Xalacom for open-angle glaucoma and ocular hypertension; and Genotropin for growth disorders. The company?s Animal Health segment offers parasiticides, anti-inflammatories, antibiotics, vaccines, antiemetics, and anti-obesity agents. It also provides Revolution/Stronghold for dogs and cats; Rimadyl for pain and inflammation associated with canine osteoarthritis and soft tissue orthopedic surgery; Clavamox/Synulox for skin and soft tissue infections; RespiSureOne/StellamuneOne to prevent pneumonia in swine; Bovi-Shield Gold for reproductive and respiratory protection; Dectomax, an injectable and pour-on formulations; Draxxin, an antibiotic for infections in cattle and swine; and Excede to treat infections in dairy cows, beef cattle, and swine. Pfizer Inc. also involves in contract manufacturing and bulk pharmaceutical chemicals businesses. It serves doctors, nurse practitioners, physician assistants, pharmacists, hospitals, pharmacy benefit managers, managed care organizations, and government agencies. The company was founded in 1849 and is headquartered in New York, New York.

PFIZER INC(NYSE: PFE) KEY EXECUTIVES

Mr. Jeffrey B. Kindler , 53 Chairman, Chief Exec. Officer, Chairman of Exec. Committee and Chairman of Exec. Compliance Committee $ 4.58M $ 0

Mr. Frank A. D'Amelio , 51 Chief Financial Officer, Sr. VP of Bus. Operations and Member of Exec. Compliance Committee $ 2.30M $ 0

Mr. Ian C. Read , 55 Group Pres of Worldwide Biopharmaceutical Bus.es and Member of Exec. Compliance Committee $ 2.30M $ 0

Mr. Martin Mackay , 52 Pres of PharmaTherapeutics R&D $ 2.29M $ 0

Mr. Natale S. Ricciardi , 60 Pres of Manufacturing N/A N/A


Our FREE iPhone App gives Buy-Sell-Hold ratings for 1,200 stocks!
 1. Dow 30+ - 200 Stocks   on 5/22/2013:   Buy   60% or 121    Hold   30% or 60    Sell   10% or 19
 2. Energy - 200 Stocks   on 5/21/2013:   Buy   72% or 145    Hold   25% or 49    Sell   3% or 6
 3. Health - 200 Stocks   on 5/21/2013:   Buy   46% or 93    Hold   40% or 78    Sell   14% or 29
 4. Finance - 200 Stocks   on 5/21/2013:   Buy   70% or 139    Hold   22% or 45    Sell   8% or 16
 5. Services - 200 Stocks   on 5/21/2013:   Buy   74% or 149    Hold   22% or 42    Sell   4% or 9
 6. Tech - 200 Stocks   on 5/21/2013:   Buy   60% or 119    Hold   32% or 64    Sell   8% or 17
 
  TOTAL RATING:   Buy   64% or 766    Hold   28% or 338    Sell   8% or 96 

5/23/2013 Latest stock market news data for Pfize (NASDAQ:PFE) Stock on Thursday, May 23, 2013

 
DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

Pfizer Inc. plans to split from former animal health unit, Zoetis Inc.
Mlive Kalamazoo - 11 hours ago
Pfizer, the largest pharmaceutical company in the world, plans to convert its Zoetis Class B common stock into Zoetis Class A common stock.
Pfizer to spin off Zoetis stake to shareholders - Yahoo! News
PFIZER INC. : Zoetis To File Registration Statement; Comments on Pfizer's ... - 4-traders (press release)
Pfizer Inc. (PFE), Merck & Co., Inc. (MRK), Teva Pharmaceutical Industries Ltd ...
Insider Monkey (blog) - 12 hours ago
As mentioned above, Pfizer Inc. (NYSE:PFE) is facing some issues with its drug pipeline. Lipitor is now off patent and the company is still looking for the next big drug to replace its revenue stream.
Pfizer Inc. (PFE), Eli Lilly & Co. (LLY), Johnson & Johnson (JNJ): The ...
Insider Monkey (blog) - 14 hours ago
Investment opportunity? The men in this study were 41, so they were kids in the 1970s, long before drugs such as Pfizer Inc. (NYSE:PFE)'s Quillivant XR, Eli Lilly & Co. (NYSE:LLY)'s Strattera, Johnson & Johnson (NYSE:JNJ)'s Concerta, or Shire's ...
Johnson & Johnson (JNJ), Pfizer Inc. (PFE), Novartis AG (ADR) (NVS): Is There ...
Insider Monkey (blog) - 11 hours ago
Pfizer Inc. (NYSE:PFE) is one company that doesn't care about that silliness. After all, the detrimental effects commonly associated with aging are mostly concerned with various forms of inflammation, which is one of the major specialties of Pfizer Inc.
Johnson & Johnson (JNJ) Ex-Dividend Date Scheduled for May 23, 2013 - NASDAQ
Pfizer Inc. (PFE) Stock Checkup for May
Insider Monkey (blog) - May 21, 2013
3 Drug Launches You Need to Know in 2013: Pfizer, NPS Pharma, Ariad We dread some checkups. Some people even put them off. If you own Pfizer Inc. (NYSE:PFE) stock, though, there's no need for dread or delay. Here is your painless and free stock ...
The Home Depot, Inc. (HD), Pfizer Inc. (PFE), JPMorgan Chase & Co. (JPM ...
Insider Monkey (blog) - 10 hours ago
Home Depot, Inc. (NYSE:HD) Investors were hoping to gain more information from Fed Chairman Ben Bernanke's testimony before the congressional Joint Economic Committee this morning, but the scoop actually came much earlier and from a different ...
Stock Market News for May 22, 2013 - Market News - NASDAQ
Pfizer Inc. begins selling Viagra online to fight fake product sales
MLive.com - May 8, 2013
KALAMAZOO, MI - Pfizer Inc. is now delivering its erectile dysfunction Viagra tablets to patients who order it online to fight counterfeit product sales.
Bashful? Buy the little blue pill online - San Mateo Daily Journal
Pfizer Inc. (PFE), Hewlett-Packard Company (HPQ): Talk of Tapering Sends ...
Insider Monkey (blog) - 7 hours ago
Pfizer Inc. (NYSE:PFE) is one of only a few companies to buck the trend today, climbing 2%. Shareholders were offered the option to exchange shares of Pfizer Inc. (NYSE:PFE) for shares of Zoetis, an animal-health company Pfizer Inc. (NYSE:PFE) is fully ...
US Stocks Decline as Investors Weigh Stimulus Comments - Businessweek
PFIZER INC. : Pfizer Discontinues Phase 3 Study of Inotuzumab Ozogamicin in ...
4-traders (press release) - May 20, 2013
Pfizer Inc. announced today the discontinuation of a Phase 3 randomized, open-label, two-arm study (B1931008) evaluating the safety and efficacy of the investigational compound inotuzumab ozogamicin in patients with relapsed or refractory CD22+ ...
Correction: Pfizer-Study Halted story - Yahoo! New Zealand News
Pfizer Non-Hodgkin Lymphoma Drug Inotuzumab Ozogamicin Fails In Late ... - Medical Daily
Pfizer Inc. (PFE) and Merck & Co., Inc. (MRK) News: Expectations Of What's ...
Insider Monkey (blog) - May 17, 2013
Editor's Note: Pfizer Inc. (NYSE:PFE), Merck & Co., Inc. (NYSE:MRK), Petroleo Brasileiro Petrobras SA (NYSE:PBR), American Express Company (NYSE:AXP).
Pfizer's Buy Rating Reaffirmed at TheStreet (PFE) - Daily Political

 
DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   


U.S. News & World Report

Talk of Tapering Sends Stocks Sharply Lower
Motley Fool
Stocks quickly dropped, and as of 3:15 p.m. EDT the Dow Jones Industrial Average (DJINDICES: ^DJI ) is off 0.47%, while the S&P 500 (SNPINDEX: ^GSPC ) is down 0.84%. Pfizer (NYSE: PFE ) is one of only a few companies to buck the trend today, climbing ...
US Stocks Decline as Investors Weigh Stimulus CommentsBusinessweek
Stocks Stage Broad Advance; Bristol-Myers Leads Med Rally BMYInvestor's Business Daily
U.S. Stock Futures Are Little Changed as Saks SurgesBloomberg
Citywire.co.uk -Fox Business
all 859 news articles »

Pfizer Stock Checkup for May
Motley Fool
If you own Pfizer (NYSE: PFE ) stock, though, there's no need for dread or delay. Here is your painless and free stock checkup for the month of May. Performance There's good news and bad news for Pfizer when it comes to performance so far this year ...

and more »

Buying Pfizer Stock Brings a Great Dividend
Motley Fool
Pfizer (NYSE: PFE ) stock has been a boon for growth investors over the past year. In the last 52 weeks, the stock has surged 30%, and Pfizer has been one of the best performers on the Dow in 2013. Even with patent expirations taking a toll on the ...
Pfizer Stock Rating Reaffirmed by TheStreet (PFE)The Utah People's Post

all 5 news articles »

These 3 Stocks Are Pulling the Dow Higher
Motley Fool
Today's Dow leader is Pfizer (NYSE: PFE ) up 1.27% to $29.07. Two weeks ago Pfizer missed earnings expectations on both the top and bottom line. The poor news contributed to Pfizer being one of the Dow's worst performers for two weeks in a row.

and more »

Dividend.com (blog)

Volatile Stock Alert: Pfizer Inc. (NYSE:PFE) and Zoetis Inc. (NYSE:ZTS)
Net PR (press release)
New York, NY – (Net PR News) – 05/22/2013–smartOTCis the premiere destination for Investors and novices alike who wish to receive information on fast moving OTC stocks and undiscovered companies. Most of these companies are considered penny ...
Drugmaker Pfizer To Spin Off Rest Of Zoetis June 19 PFE ZTSInvestor's Business Daily
Pfizer (PFE) to Split Off Remaining Interest in Zoetis (ZTS)StreetInsider.com (subscription)
Pfizer (PFE) plans to spin off its remaining stake in Zoetis (ZTS) through a ...Seeking Alpha
Dividend.com (blog) -New York Business Journal -Insider Monkey (blog)
all 30 news articles »

These Dow Stocks Ignored Fed Fears
Motley Fool
Within the Dow, though, it was easy to find stocks that bucked the trend and moved higher. Pfizer (NYSE: PFE ) was the biggest gainer in the Dow, jumping more than 2% as the company said it would present nearly a dozen different abstracts for its ...


Dividend.com (blog)

Pfizer Stock Is All Grown Up
Motley Fool
Pfizer (NYSE: PFE ) stock surpassed $30 per share earlier this month. I remember when it was just a teenager. It wasn't that long ago. For most of 2011, Pfizer stock traded for less than $20 per share. Since then, it's up 40%, more than doubling the Dow.
Pfizer Stock Rating Reaffirmed by Sanford C. Bernstein (PFE)Zolmax
Pfizer, Zoetis Reporting Q1 In Wake Of Bad NewsInvestor's Business Daily
Pfizer Given New $27.00 Price Target at Leerink Swann (PFE)Daily Political
Barron's (blog) -Dividend.com (blog) -eStocksDaily
all 100 news articles »

Verizon Stock Pulls Markets Higher
Motley Fool
The big loser on the Dow was Pfizer (NYSE: PFE ) , which lost 4.5% today. The company just reported first-quarter results: Revenue fell 9% from a year ago, and earnings of $0.54 per share were $0.02 short of estimates. Lipitor's patent expiration has ...

and more »

Pfizer Stock Is Holding Back the Dow
Motley Fool
The Dow Jones Industrial Average (DJINDICES: ^DJI ) is unchanged following a worse-than-expected earnings release from Pfizer (NYSE: PFE ) and some mixed economic releases. As of 1:25 p.m. EDT the Dow is up just six points, while the S&P 500 ...
Blue Chip BluesBarron's

all 14 news articles »

Insider Monkey (blog)

Johnson & Johnson (JNJ), Pfizer Inc. (PFE), Novartis AG (ADR) (NVS): Is There ...
Insider Monkey (blog)
In the case of stock splits, you may very well see adjusted share prices rise considerably. Plus, there's always the prospect of a company's stock becoming exceedingly popular and breaking the normal rule of staying under $200 a share the way Google ...
Johnson & Johnson (JNJ) Ex-Dividend Date Scheduled for May 23, 2013NASDAQ

all 2 news articles »

 
DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   



5/23/2013 News from StockRing Blog about Pfize (NASDAQ:PFE) Stock on Thursday, May 23, 2013



Copyright © 2012 StockRing.com. All rights reserved.
Subscriber Agreement   Privacy Agreement   Stocks   MutualFunds

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither StockRing.com nor its partners shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the StockRing site, a user agrees not to redistribute the information found therein.